Management of mitochondrial stroke-like-episodes

European Journal of Neurology

Volumn 16, Issue 11, 2009, Pages 1178-1184

  Finsterer, J ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

Cerebral imaging; Encephalomyopathy; Metabolic disease; Mitochondrial disorder; Mitochondrial DNA

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL NICOTINATE; ANTIOXIDANT; ARGININE; BIOTIN; CARNITINE; COCARBOXYLASE; CREATINE; CREATININE; CYTOCHROME C; DICHLOROACETIC ACID; FLAVINE MONONUCLEOTIDE; GLYCEROL; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HUMANIN; IDEBENONE; LACTIC ACID; LIPID PEROXIDE; MERCAPTAMINE; MITOCHONDRIAL DNA; N ACETYLASPARTIC ACID; NICOTINAMIDE; NORPHENAZONE; PREDNISOLONE; PYRUVIC ACID; RIBOFLAVIN; STEROID; SUCCINIC ACID; UBIQUINONE; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN PERFUSION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENCEPHALOMYOPATHY; HUMAN; KEARNS SAYRE SYNDROME; KETOGENIC DIET; LEIGH DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MELAS SYNDROME; MERRF SYNDROME; MONOTHERAPY; NEUROIMAGING; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYPHARMACY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PULMONARY HYPERTENSION; RECOMMENDED DRUG DOSE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; STROKE LIKE EPISODE; STROKE LIKE EPISODES; TREATMENT OUTCOME;

BRAIN; BRAIN DISEASES, METABOLIC, INBORN; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MITOCHONDRIA; STROKE;

EID: 70350135504     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02789.x     Document Type: Review

References (61)

1. Oppenheim C, Galanaud D, Samson Y, et al. Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like-events in MELAS? J Neurol Neurosurg Psychiatry 2000 69 : 248 250.
2. Finsterer J. MELAS-syndrome as a differential diagnosis of ischemic stroke. Fortschr Neurol Psychiatr 2009 77 : 25 31.
3. Iizuka T. Pathogenesis and treatment of stroke-like-episodes in MELAS. Rinsho Shinkeigaku 2008 48 : 1006 1009.
4. Chiyonobu T, Noda R, Yoshida M, et al. Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like-episodes (MELAS) associated with phenytoin therapy. Brain Dev 2008 30 : 430 433.
5. Salih MA, Abdel-Gader AG, Zahraa JN, et al. Stroke due to mitochondrial disorders in Saudi children. Saudi Med J 2006 27 (Suppl. 1 S81 S90.
6. Hirano M, Ricci E, Koenigsberger MR, et al. MELAS: an original case and clinical criteria for diagnosis. Neuromuscul Disord 1992 2 : 125 135.
7. Kanaumi T, Hirose S, Goto Y, Naitou E, Mitsudome A. An infant with a mitochondrial A3243G mutation demonstrating the MELAS phenotype. Pediatr Neurol 2006 34 : 235 238.
8. Bohnen NI, Beran-Koehn M, Mullan B, Fulgham JR. Crossed cerebro-cellular diaschisis in a patients with MELAS with aphasia but without hemiparesis. Int J Neurosci 1998 93 : 181 184.
9. Gropen TI, Prohovnik I, Tatemichi TK, Hirano M. Cerebral hyperemia in MELAS. Stroke 1994 25 : 1873 1876.
10. Yanagihara C, Oyama A, Tanaka M, Nakaji K, Nishimura Y. An autopsy case of mitochondrial encephalomyopathy with lactic acidosis and stroke-like-episodes syndrome with chronic renal failure. Intern Med 2001 40 : 662 665.
11. Fang W, Huang CC, Lee CC, Cheng SY, Pang CY, Wei YH. Ophthalmologic manifestations in MELAS-syndrome. Arch Neurol 1993 50 : 977 980.
12. Klein A, Fasnacht M, Huisman TA, Neuhaus TJ, Martin E, Boltshauser E. Siblings with infantile cerebral stroke and delayed multivessel involvement - a new hereditary vasculopathy? Eur J Paediatr Neurol 2007 11 : 292 296.
13. Lindberg C, Moslemi AR, Oldfors A. MELAS-syndrome in a patient with a point mutation in MTTS1. Acta Neurol Scand 2008 117 : 128 132.
14. Pérez López-Fraile MI, Barrena R, Montoya J, Marta E. Evolution until death of two members of a family with A3243G mutation and MELAS phenotype versus diabetes mellitus. Neurologia 2006 21 : 327 332.
15. Iizuka T, Sakai F, Suzuki N, et al. Neuronal hyperexcitability in stroke-like-episodes of MELAS-syndrome. Neurology 2002 59 : 816 824.
16. Maeda K, Tatsumi M, Tahara M, Murata Y, Kawai H, Yasuda H. A case of stroke-like-episode of MELAS of which progressive spread would be prevented by edaravone. Rinsho Shinkeigaku 2005 45 : 416 421.
17. Rossi FH, Okun M, Yachnis A, Quisling R, Triggs WJ. Corticosteroid treatment of mitochondrial encephalomyopathies. Neurologist 2002 8 : 313 315.
18. Barak Y, Arnon S, Wolach B, et al. MELAS-syndrome: peripheral neuropathy and cytochrome-c-oxidase deficiency: a case report and review of the literature. Isr J Med Sci 1995 31 : 224 229.
19. Ishikawa Y, Asuwa N, Ishii T, et al. Severe mitochondrial cardiomyopathy and extra-neuromuscular abnormalities in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like-episode (MELAS). Pathol Res Pract 1995 191 : 64 69.
20. Furuya H, Sugimura T, Yamada T, Hayashi K, Kobayashi T. A case of incomplete Kearns-Sayre syndrome with a stroke-like-episode. Rinsho Shinkeigaku 1997 37 : 680 684.
21. Lönnqvist T, Paetau A, Valanne L, Pihko H. Recessive twinkle mutations cause severe epileptic encephalopathy. Brain 2009 132 : 1553 1562.
22. Bataillard M, Chatzoglou E, Rumbach L, et al. Atypical MELAS-syndrome associated with a new mitochondrial tRNA glutamine point mutation. Neurology 2001 56 : 405 407.
23. Vallée L, Fontaine M, Nuyts JP, et al. Stroke, hemiparesis and deficient mitochondrial beta-oxidation. Eur J Pediatr 1994 153 : 598 603.
24. Morin C, Dubé J, Robinson BH, et al. Stroke-like-episodes in autosomal recessive cytochrome-oxidase deficiency. Ann Neurol 1999 45 : 389 392.
25. Ishikawa N, Tajima G, Ono H, Kobayashi M. Different neuroradiological findings during two stroke-like-episodes in a patient with a congenital disorder of glycosylation type Ia. Brain Dev 2009 31 : 240 243.
26. van Baalen A, Stephani U, Rohr A. Increased brain lactate during stroke-like-episode in a patient with congenital disorder of glycosylation type Ia. Brain Dev 2009 31 : 183.
27. Wheeler PG, Medina S, Dusick A, et al. Livedo reticularis, developmental delay and stroke-like-episode in a 7-year-old male. Clin Dysmorphol 1998 7 : 69 74.
28. Broyer M, Tête MJ, Guest G, Berthélémé JP, Labrousse F, Poisson M. Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine. J Inherit Metab Dis 1996 19 : 65 75.
29. Ohshita T, Oka M, Imon Y, et al. Serial diffusion-weighted imaging in MELAS. Neuroradiology 2000 42 : 651 656.
30. Kamada K, Takeuchi F, Houkin K, et al. Reversible brain dysfunction in MELAS: MEG, and (1)H MRS analysis. J Neurol Neurosurg Psychiatry 2001 70 : 675 678.
31. Clark JM, Marks MP, Adalsteinsson E, et al. MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 1996 46 : 223 227.
32. Iizuka T, Goto Y, Miyakawa S, et al. Progressive carotid artery stenosis with a novel tRNA phenylalanine mitochondrial DNA mutation. J Neurol Sci 2009 278 : 35 40.
33. Betts J, Jaros E, Perry RH, et al. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol 2006 32 : 359 373.
34. Takahashi N, Shimada T, Murakami Y, et al. Vascular involvement in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like-episodes. Am J Med Sci 2005 329 : 265 266.
35. Takahashi S, Tohgi H, Yonezawa H, Obara S, Nagane Y. Cerebral blood flow and oxygen metabolism before and after a stroke-like-episode in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like-episodes (MELAS). J Neurol Sci 1998 158 : 58 64.
36. Ito H, Mori K, Harada M, et al. Serial brain imaging analysis of stroke-like-episodes in MELAS. Brain Dev 2008 30 : 483 488.
37. Shimizu T, Yamashita Y, Satoi M, et al. Heat stroke-like-episode in a child caused by zonisamide. Brain Dev 1997 19 : 366 368.
38. Jian-Ren L. Precipitation of stroke-like-event by chickenpox in a child with MELAS-syndrome. Neurol India 2005 53 : 323 325.
39. Barisic N, Bernert G, Ipsiroglu O, et al. Effects of oral creatine supplementation in a patient with MELAS phenotype and associated nephropathy. Neuropediatrics 2002 33 : 157 161.
40. Ihara Y, Hayabara T, Namba R, Nobukuni K, Mori A. Free radical, lipid peroxide and antioxidant in mitochondrial encephalomyopathy. Rinsho Shinkeigaku 1994 34 : 593 595.
41. Nakano K, Tarashima M, Tachikawa E, et al. Platelet mitochondrial evaluation during cytochrome-c and dichloroacetate treatments of MELAS. Mitochondrion 2005 5 : 426 433.
42. Fujii K, Tanabe Y, Kobayashi K, Uchikawa H, Kohno Y. Detection of 14-3-3 protein in the cerebrospinal fluid in mitochondrial encephalopathy with lactic acidosis and stroke-like-episodes. J Neurol Sci 2005 239 : 115 118.
43. Tzoulis C, Bindoff LA. Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like-episodes. Stroke 2009 40 : e15 e17.
44. Abe K, Inui T, Hirono N, Mezaki T, Kobayashi Y, Kameyama M. Fluctuating MR images with mitochondrial encephalopathy, lactic acidosis, stroke-like-syndrome (MELAS). Neuroradiology 1990 32 : 77.
45. Peng NJ, Liu RS, Li JY, et al. Increased cerebral blood flow in MELAS shown by Tc-99m HMPAO brain SPECT. Neuroradiology 2000 42 : 26 29.
46. Tsujikawa T, Yoneda M, Shimizu Y, et al. Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images. Brain Dev 2009 In press).
47. Pavlakis SG, Kingsley PB, Kaplan GP, Stacpoole PW, O'Shea M, Lustbader D. Magnetic resonance spectroscopy: use in monitoring MELAS treatment. Arch Neurol 1998 55 : 849 852.
48. Wilichowski E, Pouwels PJ, Frahm J, Hanefeld F. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 1999 30 : 256 263.
49. Sano M, Ishii K, Momose Y, Uchigata M, Senda M. Cerebral metabolism of oxygen and glucose in a patient with MELAS-syndrome. Acta Neurol Scand 1995 92 : 497 502.
50. Kubota M, Sakakihara Y, Mori M, Yamagata T, Momoi-Yoshida M. Beneficial effect of L-arginine for stroke-like-episode in MELAS. Brain Dev 2004 26 : 481 483.
51. Oguro H, Iijima K, Takahashi K, et al. Successful treatment with succinate in a patient with MELAS. Intern Med 2004 43 : 427 431.
52. Tanaka J, Nagai T, Arai H, et al. Treatment of mitochondrial encephalomyopathy with a combination of cytochrome-C and vitamins B1 and B2. Brain Dev 1997 19 : 262 267.
53. Napolitano A, Salvetti S, Vista M, Lombardi V, Siciliano G, Giraldi C. Long-term treatment with idebenone and riboflavin in a patient with MELAS. Neurol Sci 2000 21 (Suppl. 5 S981 S982.
54. Koga Y. L-arginine therapy on MELAS. Rinsho Shinkeigaku 2008 48 : 1010 1012.
55. Moutaouakil F, El Otmani H, Fadel H, Sefrioui F, Slassi I. L-arginine efficiency in MELAS-syndrome. A case report. Rev Neurol (Paris) 2009 165 : 482 485.
56. Toribe Y, Tominaga K, Ogawa K, Suzuki Y. Usefulness of L-arginine infusion for status epilepticus in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like-episodes. No To Hattatsu 2007 39 : 38 43.
57. Koga Y, Akita Y, Nishioka J, et al. MELAS and L-arginine therapy. Mitochondrion 2007 7 : 133 139.
58. Majamaa K, Rusanen H, Remes AM, Pyhtinen J, Hassinen IE. Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS-syndrome. Life Sci 1996 58 : 691 699.
59. Ikejiri Y, Mori E, Ishii K, Nishimoto K, Yasuda M, Sasaki M. Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS. Neurology 1996 47 : 583 585.
60. Kaufmann P, Engelstad K, Wei Y, et al. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 2006 66 : 324 330.
61. Kariya S, Hirano M, Furiya Y, Sugie K, Ueno S. Humanin detected in skeletal muscles of MELAS patients: a possible new therapeutic agent. Acta Neuropathol 2005 109 : 367 372.